Adimmune Statistics

Total Valuation

Adimmune has a market cap or net worth of TWD 7.40 billion. The enterprise value is 8.27 billion.

Market Cap	7.40B
Enterprise Value	8.27B

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Adimmune has 421.51 million shares outstanding.

Current Share Class	421.51M
Shares Outstanding	421.51M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.03%
Owned by Institutions (%)	2.94%
Float	318.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.67
PB Ratio	1.40
P/TBV Ratio	1.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-29.32
EV / Sales	5.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.22

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.51.

Current Ratio	2.66
Quick Ratio	1.87
Debt / Equity	0.51
Debt / EBITDA	n/a
Debt / FCF	-5.32
Interest Coverage	-11.55

Financial Efficiency

Return on equity (ROE) is -7.18% and return on invested capital (ROIC) is -2.75%.

Return on Equity (ROE)	-7.18%
Return on Assets (ROA)	-2.60%
Return on Invested Capital (ROIC)	-2.75%
Return on Capital Employed (ROCE)	-5.21%
Revenue Per Employee	2.81M
Profits Per Employee	-500,059
Employee Count	564
Asset Turnover	0.18
Inventory Turnover	1.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.87% in the last 52 weeks. The beta is 0.40, so Adimmune's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-36.87%
50-Day Moving Average	18.77
200-Day Moving Average	22.77
Relative Strength Index (RSI)	36.17
Average Volume (20 Days)	2,477,580

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Adimmune had revenue of TWD 1.59 billion and -282.03 million in losses. Loss per share was -0.67.

Revenue	1.59B
Gross Profit	397.09M
Operating Income	-368.46M
Pretax Income	-391.16M
Net Income	-282.03M
EBITDA	-188.79M
EBIT	-368.46M
Loss Per Share	-0.67

Full Income Statement

Balance Sheet

The company has 2.14 billion in cash and 2.71 billion in debt, giving a net cash position of -572.41 million or -1.36 per share.

Cash & Cash Equivalents	2.14B
Total Debt	2.71B
Net Cash	-572.41M
Net Cash Per Share	-1.36
Equity (Book Value)	5.30B
Book Value Per Share	11.87
Working Capital	2.09B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -191.70 million and capital expenditures -318.14 million, giving a free cash flow of -509.84 million.

Operating Cash Flow	-191.70M
Capital Expenditures	-318.14M
Free Cash Flow	-509.84M
FCF Per Share	-1.21

Full Cash Flow Statement

Margins

Gross margin is 25.05%, with operating and profit margins of -23.24% and -17.79%.

Gross Margin	25.05%
Operating Margin	-23.24%
Pretax Margin	-24.68%
Profit Margin	-17.79%
EBITDA Margin	-11.91%
EBIT Margin	-23.24%
FCF Margin	n/a

Dividends & Yields

Adimmune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.81%
FCF Yield	-6.89%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Adimmune has an Altman Z-Score of 2.48. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.48
Piotroski F-Score	n/a